| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.EJSO.2006.03.011 |
| P698 | PubMed publication ID | 16621425 |
| P50 | author | Luigi Mariani | Q40407112 |
| Marcello Deraco | Q43800082 | ||
| Dario Baratti | Q43800097 | ||
| Antonino Ditto | Q45354972 | ||
| Shigeki Kusamura | Q59555769 | ||
| P2093 | author name string | Laterza B | |
| Raspagliesi F | |||
| Zanaboni F | |||
| de Souza GA | |||
| Campos Torres JC | |||
| Younan R | |||
| P433 | issue | 6 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 671-675 | |
| P577 | publication date | 2006-04-18 | |
| P1433 | published in | European Journal of Surgical Oncology | Q2345728 |
| P1476 | title | Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan | |
| P478 | volume | 32 |
| Q34510371 | Comparison of hyperthermia and adrenaline to enhance the intratumoral accumulation of cisplatin in a murine model of peritoneal carcinomatosis |
| Q99726592 | Current status of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in the United States |
| Q42655076 | Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. |
| Q43765205 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial. |
| Q44623386 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experience |
| Q42364442 | DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy |
| Q36128985 | Diagnosis and management of peritoneal metastases from ovarian cancer |
| Q83256036 | Hyperthermic intraperitoneal chemotherapy in the management of ovarian cancer: A critical need for an evidence-based evaluation |
| Q33405507 | Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: a pilot study |
| Q37585146 | Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results |
| Q38171356 | Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise |
| Q36444374 | Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy. |
| Q86194215 | Intraperitoneal hyperthermic chemotherapy: which drugs? |
| Q58766340 | Peritoneal carcinomatosis |
| Q26768299 | Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomes |
| Q36758929 | The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review. |
| Q38131754 | The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse. |
| Q84910382 | The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer |
| Q53571926 | Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery. |
| Q36987501 | Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals |
| Q89424650 | [Surgical treatment of peritoneal metastases from gynecological primary tumors] |
Search more.